Giovanni Luca Romano

Prof. Giovanni Luca Romano

Department of Biomedical and Biotechnological Sciences -School of Medicine - University of Catania
Department of Medicine and Surgery University of Enna Kore

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Luca FiorilloLuca Fiorillo
Luca Fiorillo
Gabriele CervinoGabriele Cervino
Gabriele Cervino
Marco MatareseMarco Matarese
Marco Matarese
CDCesare D'Amico
Cesare D'Amico
GSGiovanni Surace
Giovanni Surace
Marco CicciùMarco Cicciù
Marco Cicciù
Recently, due to the coronavirus pandemic, many guidelines and anti-contagion strategies continue to report unclear information about the persistence of coronavirus disease 2019 (COVID-19) in the environment. This certainly generates insecurity and fear in people, with an important psychological component that is not to be underestimated at this stage of the pandemic. The purpose of this article is to highlight all the sources currently present in the literature concerning the persistence of the different coronaviruses in the environment as well as in medical and dental settings. As this was a current study, there are still not many sources in the literature, and scientific strategies are moving towards therapy and diagnosis, rather than knowing the characteristics of the virus. Such an article could be an aid to summarize virus features and formulate new guidelines and anti-spread strategies.

30 March 2017 in Frontiers in Pharmacology
Verified
Journal Article
Open access
Giovanni Luca RomanoGiovanni Luca Romano
Giovanni Luca Romano
Chiara B. M. PlataniaChiara B. M. Platania
Chiara B. M. Platania
FDFilippo Drago
Filippo Drago
SSSalvatore Salomone
Salvatore Salomone
Maria Alessandra RagusaMaria Alessandra Ragusa
Maria Alessandra Ragusa
Claudio BucoloClaudio Bucolo
Claudio Bucolo
Age related macular degeneration (AMD) is the leading cause of blindness among people aged 50 and over. Retinal deposition of amyloid-β (Aβ) aggregates in AMD patients has suggested a potential link between AMD and Alzheimer’s disease (AD). We have evaluated the differential retinal expression profile of miRNAs in a rat model of AMD elicited by Aβ. A serum profile of miRNAs in AMD patients has been also assessed using single TaqMan assay. Analysis of retina from rats intravitreally injected with Aβ revealed that miR-27a, miR-146a and miR-155 were up-regulated in comparison to control rats. Seven miRNA (miR-9, miR-23a, miR-27a, miR-34a, miR-126, miR-146a and miR-155) have been found to be dysregulated in serum of AMD patients in comparison to control group. Analysis of pathways has revealed that dysregulated miRNAs, both in the AMD animal model and in AMD patients, can target genes regulating pathways linked to neurodegeneration and inflammation, reinforcing the hypothesis that AMD is a protein misfolding disease similar to AD. In fact, miR-9, miR-23a, miR-27a, miR-34a, miR-146a, miR-155 have been found to be dysregulated both in AMD and AD. In conclusion, we suggest that miR-9, miR-23a, miR-27a, miR-34a, miR-146a, miR-155 represent potential biomarkers and new pharmacological targets for AMD.

29 October 2015 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
CPChiara B. M. Platania
Chiara B. M. Platania
LPLuisa Di Paola
Luisa Di Paola
GLGian Marco Leggio
Gian Marco Leggio
Giovanni Luca RomanoGiovanni Luca Romano
Giovanni Luca Romano
FDFilippo Drago
Filippo Drago
Claudio BucoloClaudio Bucolo
Claudio Bucolo
Anti-angiogenic agents are biological drugs used for treatment of retinal neovascular degenerative diseases. In this study, we aimed at in-silico analysis of interaction of vascular endothelial growth factor A (VEGFA), the main mediator of angiogenesis, with binding domains of anti-angiogenic agents used for treatment of retinal diseases, such as ranibizumab, bevacizumab and aflibercept. The analysis of anti-VEGF/VEGFA complexes was carried out by means of protein-protein docking and molecular dynamics (MD) coupled to molecular mechanics-Poisson Boltzmann Surface Area (MM-PBSA) calculation. Molecular dynamics simulation was further analyzed by protein contact networks. Rough energetic evaluation with protein-protein docking scores revealed that aflibercept/VEGFA complex was characterized by electrostatic stabilization, whereas ranibizumab and bevacizumab complexes were stabilized by Van der Waals (VdW) energy term; these results were confirmed by MM-PBSA. Comparison of MM-PBSA predicted energy terms with experimental binding parameters reported in literature indicated that the high association rate (Kon) of aflibercept to VEGFA was consistent with high stabilizing electrostatic energy. On the other hand, the relatively low experimental dissociation rate (Koff) of ranibizumab may be attributed to lower conformational fluctuations of the ranibizumab/VEGFA complex, higher number of contacts and hydrogen bonds in comparison to bevacizumab and aflibercept. Thus, the anti-angiogenic agents have been found to be considerably different both in terms of molecular interactions and stabilizing energy. Characterization of such features can improve the design of novel biological drugs potentially useful in clinical practice.

15 February 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Claudio BucoloClaudio Bucolo
Claudio Bucolo
FDFilippo Drago
Filippo Drago
RMRosa Maisto
Rosa Maisto
Giovanni Luca RomanoGiovanni Luca Romano
Giovanni Luca Romano
Velia D'AgataVelia D'Agata
Velia D'Agata
SGSalvatore Giunta
Salvatore Giunta

1 August 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ALAntonio Leonardi
Antonio Leonardi
Claudio BucoloClaudio Bucolo
Claudio Bucolo
Giovanni Luca RomanoGiovanni Luca Romano
Giovanni Luca Romano
Chiara B. M. PlataniaChiara B. M. Platania
Chiara B. M. Platania
Filippo DragoFilippo Drago
Filippo Drago
Rosario PignatelloRosario Pignatello
Rosario Pignatello

11 February 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
Luca FalzoneLuca Falzone
Luca Falzone
Giovanni Luca RomanoGiovanni Luca Romano
Giovanni Luca Romano
RSRossella Salemi
Rossella Salemi
Claudio BucoloClaudio Bucolo
Claudio Bucolo
BTBarbara Tomasello
Barbara Tomasello
SCSaverio Candido
Saverio Candido
Uveal melanoma (UM) represents the most frequent primary tumor of the eye. Despite the development of new drugs and screening programs, the prognosis of patients with UM remains poor and no effective prognostic biomarkers are yet able to identify high‑risk patients. Therefore, in the present study, microRNA (miRNA or miR) expression data, contained in the TCGA UM (UVM) database, were analyzed in order to identify a set of miRNAs with prognostic significance to be used as biomarkers in clinical practice. Patients were stratified into 2 groups, including tumor stage (high‑grade vs. low‑grade) and status (deceased vs. alive); differential analyses of miRNA expression among these groups were performed. A total of 20 deregulated miRNAs for each group were identified. In total 7 miRNAs were common between the groups. The majority of common miRNAs belonged to the miR‑506‑514 cluster, known to be involved in UM development. The prognostic value of the 20 selected miRNAs related to tumor stage was assessed. The deregulation of 12 miRNAs (6 upregulated and 6 downregulated) was associated with a worse prognosis of patients with UM. Subsequently, miRCancerdb and microRNA Data Integration Portal bioinformatics tools were used to identify a set of genes associated with the 20 miRNAs and to establish their interaction levels. By this approach, 53 different negatively and positively associated genes were identified. Finally, DIANA‑mirPath prediction pathway and Gene Ontology enrichment analyses were performed on the lists of genes previously generated to establish their functional involvement in biological processes and molecular pathways. All the miRNAs and genes were involved in molecular pathways usually altered in cancer, including the mitogen‑activated protein kinase (MAPK) pathway. Overall, the findings of the presents study demonstrated that the miRNAs of the miR‑506‑514 cluster, hsa‑miR‑592 and hsa‑miR‑199a‑5p were the most deregulated miRNAs in patients with high‑grade disease compared to those with low‑grade disease and were strictly related to the overall survival (OS) of the patients. However, further in vitro and translational approaches are required to validate these preliminary findings.